Antimicrobial Stewardship Program

Role of Antimicrobial Stewardship

To promote the appropriate use of antimicrobials, reduce antimicrobial resistance, and spread of infection caused by multi-drug-resistant organisms and reduce the spread of infection, with the goal of promoting improved patient outcomes in both inpatient and outpatient settings.

Vision Statement

To be a nationally recognized antimicrobial stewardship program that holistically promotes patient safety and improves patient outcomes through novel innovations.

Resource Updates

Drug-Susceptible Tuberculosis Therapy Guideline (PDF) (updated 6/2025)
Pre-Incision Antibiotics for Cesarean Delivery Algorithm (updated 2/2025)
LPCH Blue Card – Antibiogram and Antimicrobial Dosing Quick Reference Card (updated 2/2025)
Inpatient Antibiogram (updated 2/2025)
Guidelines for Initial Therapy for Common Pediatric Infections (updated 1/2025)
Amoxicillin-clavulanate (Augmentin®) Dosing Guide (PDF) (updated 1/2025)

Program Updates

Apr 2024                  Stanford Medicine Children’s Health ASP Program again recognized by IDSA Center of Excellence
Jan 2024                     Stanford Medicine Children’s Health ASP program again recognized by CDPH HAI Antimicrobial Stewardship Honor Roll and designated with GOLD status
Jul 2023      Welcome Lauren Kushner, MD, new associate medical director for ASP
Jul 2022 ASP Website Launch
Nov 2021 Offering of PGY2 Pediatric Infectious Diseases Residency
May 2021 Global Changes to Vancomycin Reaction

All content and media on the Pediatric Antimicrobial Stewardship Program's website is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice.